Viewing Study NCT06600802

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2026-01-22 @ 12:35 AM
Study NCT ID: NCT06600802
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2024-07-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
Sponsor: Centre Jean Perrin
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration-resistant Metastatic Prostate Cancer View
None Treated by 177Lutetium-PSMA-617 (Lu-PSMA) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mCRPC View
None Lu-PSMA View
None biomarkers View
None response View
None prediction View